279 related articles for article (PubMed ID: 9017770)
61. Tolerability of enalapril in mild to moderate hypertension.
Sharma S; Gupta U; Bapna JS; Sahai A
J Assoc Physicians India; 1995 Jul; 43(7):475-6. PubMed ID: 8713222
[No Abstract] [Full Text] [Related]
62. Diltiazem: its place in the antihypertensive armamentarium.
Fagan TC
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S26-31. PubMed ID: 1725539
[TBL] [Abstract][Full Text] [Related]
63. [Diltiazem 180 mg in delayed release formulation in mild and moderate arterial hypertension].
Serra-Pinto L; Baptista A; Rocha E
Rev Port Cardiol; 1995 Apr; 14(4):303-10, 283-4. PubMed ID: 7612279
[TBL] [Abstract][Full Text] [Related]
64. [The Berlipril and Retalzem treatment of hypertension patients: the dynamics of the clinico-hemodynamic indices and of the vasodilating humoral factors].
Koval' SN; Starchenko TG; Gorb IuG; Pen'kova MIu; Khasanova KhD
Lik Sprava; 1999; (1):113-7. PubMed ID: 10424019
[TBL] [Abstract][Full Text] [Related]
65. An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy.
Burris JF; Weir MR; Oparil S; Weber M; Cady WJ; Stewart WH
JAMA; 1990 Mar; 263(11):1507-12. PubMed ID: 2407872
[TBL] [Abstract][Full Text] [Related]
66. The neglected time factor and antihypertensive therapy. A pitfall in evaluating side effects in a cross-over study.
Edmonds D; Greminger P; Vetter W; Baumgart P; Vetter H
Postgrad Med; 1988 Feb; Spec No():40-5. PubMed ID: 2831525
[TBL] [Abstract][Full Text] [Related]
67. Comparative antihypertensive effectiveness of once-daily mibefradil and diltiazem CD. Mibefradil Hypertension Study Group.
Bittar N
Clin Ther; 1997; 19(5):954-62. PubMed ID: 9385483
[TBL] [Abstract][Full Text] [Related]
68. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
Graney WF
Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
[TBL] [Abstract][Full Text] [Related]
69. Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension.
Seravalle G; Brambilla G; Pizzalla DP; Casati A; Riva M; Cuspidi C; Bombelli M; Mancia G; Grassi G
J Am Soc Hypertens; 2016 Mar; 10(3):244-51. PubMed ID: 26831124
[TBL] [Abstract][Full Text] [Related]
70. Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension.
Küppers HE; Jäger BA; Luszick JH; Gräve MA; Hughes PR; Kaan EC
J Hypertens; 1997 Jan; 15(1):93-7. PubMed ID: 9050976
[TBL] [Abstract][Full Text] [Related]
71. Effect of enalapril and nifedipine on orthostatic hypotension in older hypertensive patients.
Slavachevsky I; Rachmani R; Levi Z; Brosh D; Lidar M; Ravid M
J Am Geriatr Soc; 2000 Jul; 48(7):807-10. PubMed ID: 10894321
[TBL] [Abstract][Full Text] [Related]
72. Effects of long-term administration of diltiazem hydrochloride in hypertensive patients.
Sawai K
Clin Ther; 1983; 5(4):422-35. PubMed ID: 6871924
[TBL] [Abstract][Full Text] [Related]
73. Optimization of antihypertensive therapy with a novel, extended-release formulation of diltiazem: results of a practice-based clinical study.
Neutel JM; Smith DH; Frishman WH
Clin Ther; 1997; 19(6):1379-93. PubMed ID: 9444447
[TBL] [Abstract][Full Text] [Related]
74. Arterial vasodilator and antihypertensive effects of diltiazem.
Kiowski W; Linder L; Bühler FR
J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S7-10. PubMed ID: 1707118
[TBL] [Abstract][Full Text] [Related]
75. [Ambulatory measurement of blood pressure and efficacy of diltiazem. Influence of the timing of drug ingestion and initial blood pressure level].
Bernard-Fernier MF; Renucci JF; Siche JP; Vaisse B; Poggi L; Mallion JM
Ann Cardiol Angeiol (Paris); 1994 Jun; 43(6):357-64. PubMed ID: 8085776
[TBL] [Abstract][Full Text] [Related]
76. Enalapril: benefit-to-risk ratio in hypertensive patients.
Gomez HJ; Cirillo VJ; Smith SG
J Cardiovasc Pharmacol; 1990; 15 Suppl 3():S26-9. PubMed ID: 1691415
[TBL] [Abstract][Full Text] [Related]
77. Effect of diltiazem hydrochloride in essential hypertension.
Akanabe H; Ishiguro M; Yagi Y; Ohshima S; Ohmae M; Mori H; Watanabe S; Yasue T
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):63-9. PubMed ID: 3886566
[TBL] [Abstract][Full Text] [Related]
78. Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.
Weir MR; Chrysant SG; McCarron DA; Canossa-Terris M; Cohen JD; Gunter PA; Lewin AJ; Mennella RF; Kirkegaard LW; Hamilton JH; Weinberger MH; Weder AB
Hypertension; 1998 May; 31(5):1088-96. PubMed ID: 9576119
[TBL] [Abstract][Full Text] [Related]
79. Enalapril and diltiazem co-administration and respiratory side effects of enalapril.
Franová S; Nosál'ová G; Antosová M; Nosál' S
Physiol Res; 2005; 54(5):515-20. PubMed ID: 15641937
[TBL] [Abstract][Full Text] [Related]
80. Angiotensin-converting enzyme inhibitor versus calcium antagonist in the treatment of hypertension.
Brunner HR; Bidiville J; Waeber G; Porchet M; Nussberger J; Waeber B
Nephron; 1987; 47 Suppl 1():87-9. PubMed ID: 2827044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
